OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant
Jan‐Stephan Sanders, Fréderike J. Bemelman, A. Lianne Messchendorp, et al.
Transplantation (2021) Vol. 106, Iss. 4, pp. 821-834
Open Access | Times Cited: 161

Showing 1-25 of 161 citing articles:

Divergent SARS-CoV-2 Omicron–reactive T and B cell responses in COVID-19 vaccine recipients
Corine H. GeurtsvanKessel, Daryl Geers, Katharina S. Schmitz, et al.
Science Immunology (2022) Vol. 7, Iss. 69
Open Access | Times Cited: 404

Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming
Roos S. G. Sablerolles, Wim J. R. Rietdijk, Abraham Goorhuis, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 10, pp. 951-963
Open Access | Times Cited: 116

Immunogenicity and Risk Factors Associated With Poor Humoral Immune Response of SARS-CoV-2 Vaccines in Recipients of Solid Organ Transplant
Kasama Manothummetha, Nipat Chuleerarux, Anawin Sanguankeo, et al.
JAMA Network Open (2022) Vol. 5, Iss. 4, pp. e226822-e226822
Open Access | Times Cited: 87

Clinical Characteristics and Outcomes of Immunocompromised Patients With Coronavirus Disease 2019 Caused by the Omicron Variant: A Prospective, Observational Study
S. Reshwan K. Malahe, Rogier A.S. Hoek, Virgil A. S. H. Dalm, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e172-e178
Open Access | Times Cited: 78

Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19
Sabine Haggenburg, Quincy Hofsink, Birgit I. Lissenberg‐Witte, et al.
JAMA Oncology (2022) Vol. 8, Iss. 10, pp. 1477-1477
Open Access | Times Cited: 62

Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity
Leanne P. M. van Leeuwen, Corine H. GeurtsvanKessel, Pauline M. Ellerbroek, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 149, Iss. 6, pp. 1949-1957
Open Access | Times Cited: 60

Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients
Sabine Haggenburg, Birgit I. Lissenberg‐Witte, Rob van Binnendijk, et al.
Blood Advances (2022) Vol. 6, Iss. 5, pp. 1537-1546
Open Access | Times Cited: 55

Immunogenicity of COVID-19 vaccines in patients with diabetes mellitus: A systematic review
Amir Bahador Boroumand, Mahtab Forouhi, Farzaneh Karimi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 55

Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial
Marcia M. L. Kho, A. Lianne Messchendorp, Sophie C. Frölke, et al.
The Lancet Infectious Diseases (2022) Vol. 23, Iss. 3, pp. 307-319
Open Access | Times Cited: 53

Sotrovimab Resistance and Viral Persistence After Treatment of Immunocompromised Patients Infected With the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant
Sammy Huygens, Bas B. Oude Munnink, Arvind Gharbharan, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e507-e509
Open Access | Times Cited: 43

Humoral Response in Hemodialysis Patients Post-SARS-CoV-2 mRNA Vaccination: A Systematic Review of Literature
Kin Israel Notarte, Jesus Alfonso Catahay, Princess Juneire Peligro, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 724-724
Open Access | Times Cited: 28

The Importance of Measuring SARS-CoV-2-Specific T-Cell Responses in an Ongoing Pandemic
Linda Petrone, Alessandro Sette, Rory D. de Vries, et al.
Pathogens (2023) Vol. 12, Iss. 7, pp. 862-862
Open Access | Times Cited: 25

Post COVID-19 condition imposes significant burden in patients with advanced chronic kidney disease: A nested case-control study
Pim Bouwmans, S. Reshwan K. Malahe, A. Lianne Messchendorp, et al.
International Journal of Infectious Diseases (2024) Vol. 142, pp. 106990-106990
Open Access | Times Cited: 10

Antibody and T-Cell Responses 6 Months After Coronavirus Disease 2019 Messenger RNA-1273 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant
Jan‐Stephan Sanders, A. Lianne Messchendorp, Rory D. de Vries, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e188-e199
Open Access | Times Cited: 36

Humoral and cellular response of COVID‐19 vaccine among solid organ transplant recipients: A systematic review and meta‐analysis
Hari Shankar Meshram, Vivek Kute, Hemant Rane, et al.
Transplant Infectious Disease (2022) Vol. 24, Iss. 6
Open Access | Times Cited: 30

Prediction of humoral and cellular immune response to COVID-19 mRNA vaccination by TTV load in kidney transplant recipients and hemodialysis patients
Marianne Graninger, Julian Stumpf, Gregor Bond, et al.
Journal of Clinical Virology (2023) Vol. 162, pp. 105428-105428
Open Access | Times Cited: 16

Incidence and Severity of COVID-19 in Relation to Anti-Receptor-Binding Domain IgG Antibody Level after COVID-19 Vaccination in Kidney Transplant Recipients
A. Lianne Messchendorp, Jan‐Stephan Sanders, Alferso C Abrahams, et al.
Viruses (2024) Vol. 16, Iss. 1, pp. 114-114
Open Access | Times Cited: 6

Assessment of COVID-19 Vaccine Effectiveness Against SARS-CoV-2 Infection, Hospitalization and Death in Mexican Patients with Metabolic Syndrome from Northeast Mexico: A Multicenter Study
Beatriz Silva-Ramírez, Katia Peñuelas-Urquides, Brenda Leticia Escobedo-Guajardo, et al.
Vaccines (2025) Vol. 13, Iss. 3, pp. 244-244
Open Access

Tripartite motif 22 (TRIM22) downregulates TLR3-induced CCL5 expression in human renal proximal tubular epithelial cells
Mayuki Tachizaki, Y. Kobori, Shogo Kawaguchi, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access

Divergent SARS CoV-2 Omicron-specific T- and B-cell responses in COVID-19 vaccine recipients
Corine H. GeurtsvanKessel, Daryl Geers, Katharina S. Schmitz, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 32

Enhanced Humoral Immune Response After COVID-19 Vaccination in Elderly Kidney Transplant Recipients on Everolimus Versus Mycophenolate Mofetil–containing Immunosuppressive Regimens
Silke E. de Boer, Stefan P. Berger, Coretta van Leer‐Buter, et al.
Transplantation (2022) Vol. 106, Iss. 8, pp. 1615-1621
Open Access | Times Cited: 25

High torque tenovirus (TTV) load before first vaccine dose is associated with poor serological response to COVID-19 vaccination in lung transplant recipients
Rogier A.S. Hoek, Erik A.M. Verschuuren, Rory D. de Vries, et al.
The Journal of Heart and Lung Transplantation (2022) Vol. 41, Iss. 6, pp. 765-772
Open Access | Times Cited: 23

Immune Responses 6 Months After mRNA-1273 COVID-19 Vaccination and the Effect of a Third Vaccination in Patients with Inborn Errors of Immunity
Leanne P. M. van Leeuwen, Marloes Grobben, Corine H. GeurtsvanKessel, et al.
Journal of Clinical Immunology (2023) Vol. 43, Iss. 6, pp. 1104-1117
Open Access | Times Cited: 12

Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study
Quincy Hofsink, Sabine Haggenburg, Birgit I. Lissenberg‐Witte, et al.
EClinicalMedicine (2023) Vol. 61, pp. 102040-102040
Open Access | Times Cited: 12

Page 1 - Next Page

Scroll to top